Workflow
SenesTech(SNES)
icon
Search documents
SenesTech(SNES) - 2024 Q2 - Earnings Call Transcript
2024-08-10 00:45
SenesTech, Inc. (NASDAQ:SNES) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Robert Blum – Lytham Partners Joel Fruendt – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the SenesTech Reports Second Quarter Fiscal Year 2024 Results. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Mr. Robert Blum, Lytham Partners. Please go ah ...
SenesTech(SNES) - 2024 Q2 - Quarterly Report
2024-08-08 21:24
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-37941 SENESTECH, INC. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----- ...
SenesTech(SNES) - 2024 Q2 - Quarterly Results
2024-08-08 20:07
Exhibit 99.1 SenesTech Announces Second Quarter 2024 Financial Results Record Revenue and Margin Performance PHOENIX, Ariz., August 8, 2024. SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control products today announced financial results for the second quarter of 2024. ® Recent Highlights • Record revenues of $874,000 in the first half of 2024, an in ...
SenesTech Announces Second Quarter 2024 Financial Results
Prnewswire· 2024-08-08 20:05
Record Revenue and Margin Performance PHOENIX, Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------- ...
SenesTech to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
Prnewswire· 2024-08-01 20:15
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results. Second Quarter 2024 Conference Call Details Date and Time: Thursday, August 8, 2024, at 5 ...
IBN Announces Latest Episode of The GotStocks Podcast featuring Joel Fruendt, CEO of SenesTech Inc.
Newsfilter· 2024-07-31 12:00
The GotStocks Podcast puts the small-cap sector in the limelight with in-depth interviews featuring executives responsible for guiding gems that could be on the cusp of huge moves. The latest episode features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ:SNES), the leader in fertility control to manage animal pest populations. To begin the interview, Fruendt provided an introduction to SenesTech® and its business model. "I'll start out with this fact that usually leaves people with their jaws dr ...
SenesTech Announces Reverse Stock Split
Prnewswire· 2024-07-23 15:30
Common Stock Will Begin Trading on a Split-Adjusted Basis on July 25, 2024 PHOENIX, July 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:01 p.m, Eastern Time, on July 24, 2024. The Company ...
SenesTech's Evolve™ Fertility Control Solution for Rats To Be Deployed in the U.S. Virgin Islands
Prnewswire· 2024-06-26 13:00
"The initial multi-pallet order is already en route to the U.S. Virgin Islands, and we have reserved The Wild Ecology's regular order in our production schedule," said Joel Fruendt, the President and CEO of SenesTech. PHOENIX, June 26, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announced that Evolve™, the Company's minimum risk soft bait for the proactive control of rats, will be deployed in the ...
SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon
ZACKS· 2024-05-30 17:11
SenesTech, Inc. (SNES) , a player in the field of fertility control for managing animal pest populations, has announced the launch of its Evolve fertility control solution for rats on Amazon (AMZN) . This strategic move marks a significant advancement in the distribution of Evolve, the company's innovative minimum-risk soft bait designed for proactive rat control. More on Evolve Unlike traditional methods that rely heavily on poisons, Evolve targets the root cause of rodent overpopulation by reducing fertil ...
SenesTech to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Prnewswire· 2024-05-23 13:00
The webcasted presentation will take place at 11:45am ET on Thursday, May 30, 2024. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2024/ or directly at https://wsw.com/webcast/lytham11/snes/2110185. The webcast will also be available for replay following the event. PHOENIX, May 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate i ...